MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of Peter G. Amanatides as Vice President – Quality Assurance & Quality Control, effective immediately. In this role, Amanatides will lead all aspects of Noven’s quality functions.
